Rumii is building the first real-world model of human behavioural dynamics. the fifth -ome of human health, and the missing foundation of preventative, personalised medicine. Alongside the genome, microbiome, proteome, and metabolome, behaviour is the layer that determines whether treatments work, patients engage, and trajectories bend before crisis. It drives 60–80% of health outcomes — yet remains the least measured signal in healthcare. We call it the vivome. Rumii makes the vivome visible through passive smartphone sensing; a sixth sense for the body, capturing sleep, activity, sociability, and cognitive presence as a continuous signal between formal healthcare and clinical trial touchpoints. No wearables. No manual tracking. No added burden. For CROs, pharma, and health systems, behavioural signals become actionable risk insights — enabling earlier identification of where participants need support, improving trial retention, medication adherence, and real-world evidence quality at scale. Participants receive personalised insights and compassionate, AI-guided support that helps them stay engaged between appointments, with consent and anonymisation built in by design. A world model of behaviour under intervention. Built to predict and prevent, before crisis.
| Website | https://www.rumii.app |
| Employees | 2 (1 on RocketReach) |
| Founded | 2024 |
| Industry | Hospitals and Health Care |
Looking for a particular Rumii employee's phone or email?
Fin Williams is the Founder and CEO of Rumii.
1 people are employed at Rumii.